Evotec acquires Oxford Asymmetry

As expected, Evotec (NMarkt:EVT) will acquire Oxford Asymmetry (LSE:OAI) (see BioCentury, July 31). The new company will combine EVT's ultra-high throughput screening and assay development with OAI's...